For the decade prior to GenMark, Hawkins served in various positions of increasing responsibility across R&D, sales, marketing and manufacturing in the clinical diagnostics field for Hologic, Third Wave Technologies and Abbott Laboratories. He holds a BA in Chemistry with honors from Concordia University and an MBA from Keller Graduate School of Management.
"We are excited to welcome Jeff Hawkins to the ACMG Foundation Board of Directors. His experience in the application of genomic technologies in the healthcare arena will be a great asset in guiding Foundation initiatives in genomic medicine," said Bruce R. Korf, MD, PhD, FACMG, president of the ACMG Foundation.
The complete list of the ACMG Foundation board of directors is at http://www.acmgfoundation.org.
About the ACMG Foundation for Genetic and Genomic Medicine
The ACMG Foundation for Genetic and Genomic Medicine, a 501(c)(3) nonprofit organization, is a community of supporters and contributors who understand the importance of medical genetics and genomics in healthcare. Established in 1992, the ACMG Foundation for Genetic and Genomic Medicine supports the American College of Medical Genetics and Genomics' mission to "translate genes into health" by raising funds to attract the next generation of medical geneticists and genetic counselors, to sponsor important research, to promote information about medical genetics, and much more.
To learn more about the important mission and projects of the ACMG Foundation for Genetic and Genomic Medicine and how you too can support this great cause, please visit http://www.acmgfoundation.org or contact us at [email protected] or 301-718-2014.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/jeffrey-hawkins-of-illumina-is-elected-to-the-board-of-acmg-foundation-for-genetic-and-genomic-medicine-300446554.html
SOURCE American College of Medical Genetics and Genomics
Recommendation and review posted by Fredricko